Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors

Bioorganic & Medicinal Chemistry Letters
2015.0

Abstract

A series of alternative Zn-binding groups were explored in the design of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. Most of the synthesized compounds were less effective than the parent hydroxamic acid. However, the profile of activity shown by the analog bearing a hydroxyurea head group, makes this derivative promising for further investigation.

Knowledge Graph

Similar Paper

Investigation on the ZBG-functionality of phenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group
MedChemComm 2014.0
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0
Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
European Journal of Medicinal Chemistry 2009.0
Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-Based non-hydroxamates
Bioorganic & Medicinal Chemistry Letters 2003.0
Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group
Bioorganic & Medicinal Chemistry Letters 2004.0
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents
Bioorganic & Medicinal Chemistry Letters 2008.0